The US Patent and Trademark Office (USPTO) issued Incisive Surgical a key patent for its proprietary INSORB Absorbable Skin Stapling Technology, a new surgical modality that places an absorbable staple entirely underneath the skin to close surgical incisions.
Incisive Surgical claims the staples, which are comprised of the same material as the bioabsorbable sutures, break down naturally, thereby eliminating the anxiety, pain, cost and inconvenience of post-operative staple removal.
The allowed claims include comprehensive subject matter covering the method and apparatus of the INSORB Skin Closure technology.
The company has received a notice of allowance of patent issuance from the USPTO relating to the absorbable staple.
In addition, the Japanese Patent Office issued a notice of allowance of patent issuance covering the method and apparatus of the INSORB Technology.
The company was issued a Japanese patent in 2010 relating to its absorbable staple.
Incisive Surgical president and CEO John Shannon said they have patents covering all three essential core elements of the INSORB Technology – the method, the absorbable staple, and the mechanical stapler.